CAR7-T Cell Therapy (Beijing Gaobo Biotechnology Co Ltd)

N/A

Report date: 2024/11/24 20:00:04

Base Information

Drug NameCAR7-T Cell Therapy (Beijing Gaobo Biotechnology Co Ltd)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy
Mechanisms of ActionT-cell antigen CD7 inhibitors
TargetsT-cell antigen CD7
Therapy Area/IndicationsLymphoma, T-CellLeukemia, T-CellLeukemia, Lymphocytic, Chronic, B-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaPending
Originator CompaniesWuhan Union Hospital
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWuhan Union Hospital
Active IndicationsN/A
Inactive IndicationsLymphoma, T-CellLeukemia, T-CellLeukemia, Lymphocytic, Chronic, B-Cell

Other Information

ATC CodeN/A
Related LinksN/A